Form 4: Itron SVP Donald Reeves Sells Shares via 10b5-1 Plan
Statement of Changes in Beneficial Ownership
Itron, Inc. SVP of Outcomes Donald L. Reeves III sold 255 shares of common stock under a pre-established Rule 10b5-1 trading plan.
Summary
- Donald L. Reeves III, SVP of Outcomes at Itron, Inc., executed a sale of 255 shares of common stock.
- The transaction occurred on May 21, 2026, at a price of $80.88 per share.
- Following the transaction, Mr. Reeves retains beneficial ownership of 29,419 shares of Itron common stock.
- The sale was conducted pursuant to a Rule 10b5-1 trading plan adopted on September 11, 2025.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sale was conducted under a pre-established, automated trading plan and represents a small fraction of the executive's total holdings.
Positives
- The sale was executed under a pre-planned Rule 10b5-1 trading plan, which is a standard mechanism for executives to sell shares without triggering insider trading concerns.
Negatives
- The transaction represents a reduction in the executive's direct equity stake in the company.
Risks
- Executive stock sales can sometimes be perceived negatively by the market, though this specific sale is part of a pre-arranged plan.
Future Outlook
No specific forward-looking guidance regarding company performance was provided in this filing.
Industry Context
StockSavvy.ai notes that routine insider selling under 10b5-1 plans is a common practice for corporate executives to manage personal liquidity and is generally viewed as neutral by the investment community.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is the industry standard for executives at major technology and industrial firms to ensure compliance with SEC regulations while liquidating equity compensation.
Stakeholder Impact
- Minimal impact on shareholders as the transaction was small and pre-planned.
Key Dates
| Date | Description |
|---|---|
| 2025-09-11 | Date the Rule 10b5-1 trading plan was adopted by Mr. Reeves. |
| 2026-05-21 | Date of the reported stock sale transaction. |
| 2026-05-22 | Date the Form 4 was signed and filed. |
Keywords
Itron, ITRI, Insider Trading, Form 4, Executive Compensation, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.